Our CEO, Evan Unger is recognized by the journal "Radiology"
- MVT
- Jan 25, 2023
- 0 min read
top of page
Search
Recent Posts
See AllSalt Lake City, UT –Wednesday November, 5 th 2025— Researchers from the University of Utah and Microvascular Therapeutics (MVT) will be presenting new preclinical data demonstrating that focused ultr
Phase‑shift microbubble (also known as nanobubble) technology demonstrates robust thrombus resolution in a porcine deep vein thrombosis (DVT) model. Salt Lake City, UT – Microvascular Therapeutics, In
Chicago, IL – October 7th, 2025 – Microvascular Therapeutics (MVT), a clinical-stage biopharmaceutical company pioneering innovations in...
bottom of page
Comments